- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Health Ministry asks AIOCD to ensure availability of critical drugs for management of COVID-19
A combination of hydroxychloroquine and azithromycin has been prescribed for severe patients requiring ICU management.
New Delhi: The Union Health Ministry has written to the All India Organisation of Chemists and Druggists (AIOCD), saying its member should ensure availability of critical drugs for management of COVID-19 and other essential drugs during these "challenging times".
The ministry has forwarded a list of 55 drugs for ICU management of novel coronavirus patients and a list of another 96 drugs for general availability and treatment of various co-morbid conditions. The list was prepared following a detailed exercise undertaken by the Director General Health Services.
The letter stated that in accordance with the Clinical Management Guidelines for COVID-19, hydroxychloroquine has been recommended as prophylaxis for certain categories like healthcare workers and household contacts of positive cases.
A combination of hydroxychloroquine and azithromycin has been prescribed for severe patients requiring ICU management. Some other drugs are also presently under various stages of trials, but have so far not been recommended for use in India, the letter stated.
The ministry also acknowledged the contribution of the Indian Pharma Trade channels during these difficult times, saying they have strived to maintain availability and supply of important drugs.
"In light of this current pandemic, it is absolutely essential that sufficient market availability of these drugs along with other essential drugs is ensured by your members. These steps will go a long way in the effective clinical management of the pandemic.
"I would request to you kindly convey this message to your members so that adequate availability of the essential medicines can be ensured during this challenging time of COVID-19," the letter stated.
Following this, the AIOCD has written to all its office bearers, presidents, secretaries and executive committee members to maintain optimum availability of the drugs mentioned in the list to avoid shortage in case of emergency for ICU patients.
"Still all of us have to work hard for some more time and carefully dispense drugs like hydroxychloroquine and azithromycin which are mandated to be sold on prescriptions only," AIOCD president Jagannath Sakharam Shinde said in his communique.
"Hope you shall circulate this message to all your chemists and stockiest in your states. Social media may be used for immediate delivery. Our preparedness is must in this demanding situation as carers of needy patients are looking to us for instant life savings medicines," he said.
Read also: Lupin Launches Jan Kovid Helpline in Mumbai
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751